Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Posts Earnings Results, Misses Expectations By $0.01 EPS

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) issued its earnings results on Monday. The company reported ($0.50) EPS for the quarter, missing analysts’ consensus estimates of ($0.49) by ($0.01), FiscalAI reports. Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The business had revenue of $19.56 million during the quarter.

Here are the key takeaways from Senseonics Holdings, Inc. Common Stock’s conference call:

• Q3 revenue more than doubled year over year to a record $19.6 million, led by U.S. growth of about 160%. Senseonics raised 2026 revenue guidance for the third time, to $68 million–$70 million from $62 million–$66 million.
• Commercial indicators were strong: the company reported record new patient starts, active prescribers increased more than 90% year over year, and about nine in 10 new insertions came from patients switching from competing sensors. Management said reorder rates are ahead of plan.
• Senseonics expects to launch its Eversense 365 integration with Beta Bionics’ iLet system in the coming weeks, adding to its existing Sequel/twiist partnership. Management said it expects to be a $100 million revenue company in 2027, though formal guidance will come early next year.
• The company began human testing of Freedom, a planned CGM with no on-body component, and is targeting a pivotal study in 2027 and potential launch in 2028. These remain forward-looking milestones; the current study is an early-feasibility evaluation.
• Despite gross margin improving to about 62%, Q3 net loss widened to $32.7 million from $19.5 million a year earlier. Full-year operating expenses are expected to be slightly above the prior $150 million–$160 million range, and cash utilization is forecast at about $120 million; management expects cash-flow breakeven shortly after Freedom launches.

Senseonics Holdings, Inc. Common Stock Trading Up 30.6%

SENS traded up $3.00 during trading on Tuesday, hitting $12.80. 1,611,137 shares of the stock traded hands, compared to its average volume of 667,658. Senseonics Holdings, Inc. Common Stock has a 12-month low of $4.79 and a 12-month high of $13.98. The firm has a market capitalization of $535.00 million, a P/E ratio of -5.77 and a beta of 1.04. The firm has a 50-day moving average of $9.12 and a 200 day moving average of $7.26. The company has a debt-to-equity ratio of 0.62, a current ratio of 6.74 and a quick ratio of 6.40.

Insider Buying and Selling at Senseonics Holdings, Inc. Common Stock

In other Senseonics Holdings, Inc. Common Stock news, Director Douglas Roeder purchased 13,953 shares of the stock in a transaction that occurred on Wednesday, August 19th. The shares were bought at an average cost of $8.98 per share, with a total value of $125,297.94. Following the acquisition, the director owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 4.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Integrated Wealth Concepts LLC acquired a new stake in Senseonics Holdings, Inc. Common Stock in the second quarter valued at $36,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the 2nd quarter valued at about $65,000. State of Wyoming acquired a new stake in shares of Senseonics Holdings, Inc. Common Stock in the second quarter valued at approximately $67,000. Kestra Advisory Services LLC acquired a new position in Senseonics Holdings, Inc. Common Stock during the first quarter worth about $68,000. Finally, Cetera Investment Advisers acquired a new position in Senseonics Holdings, Inc. Common Stock in the 1st quarter worth approximately $85,000. Institutional investors and hedge funds own 12.36% of the company’s stock.

Analyst Ratings Changes

SENS has been the subject of a number of analyst reports. HC Wainwright reissued a “buy” rating and issued a $14.00 price target on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday. Wall Street Zen upgraded shares of Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 8th. Weiss Ratings raised shares of Senseonics Holdings, Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, November 4th. Raymond James Financial upgraded shares of Senseonics Holdings, Inc. Common Stock from an “underperform” rating to a “market perform” rating in a report on Tuesday. Finally, TD Cowen reiterated a “buy” rating and set a $15.00 price target on shares of Senseonics Holdings, Inc. Common Stock in a report on Tuesday, October 27th. Three investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $13.60.

Key Senseonics Holdings, Inc. Common Stock News

Here are the key news stories impacting Senseonics Holdings, Inc. Common Stock this week:

• Positive Sentiment: Senseonics raised its FY 2026 revenue guidance to $68 million–$70 million, up from $62 million–$66 million and above the $64.2 million consensus estimate. It also lifted its full-year gross-margin outlook to more than 60%. Third-quarter 2026 results
• Positive Sentiment: Third-quarter revenue was about $19.6 million, up approximately 140% year over year, and exceeded analyst revenue estimates, highlighting strong sales growth. Q3 results and revenue estimates
• Positive Sentiment: HC Wainwright reaffirmed its Buy rating and set a $14 price target. Raymond James also upgraded SENS, moving its rating from Underperform to Market Perform. HC Wainwright rating
• Negative Sentiment: The company reported a third-quarter loss of $0.50 per share, slightly worse than the $0.49 consensus loss and wider than the $0.43 loss a year earlier. Quarterly earnings results

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.